M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medicofarma Biotech SA
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Depreciation & Amortization
-zł2m
CAGR 3-Years
-268%
CAGR 5-Years
-95%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Depreciation & Amortization
-zł152k
CAGR 3-Years
50%
CAGR 5-Years
29%
CAGR 10-Years
9%
R
Ryvu Therapeutics SA
WSE:RVU
Depreciation & Amortization
-zł10.6m
CAGR 3-Years
8%
CAGR 5-Years
-5%
CAGR 10-Years
-17%
S
Selvita SA
WSE:SLV
Depreciation & Amortization
-zł49m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Depreciation & Amortization?
Depreciation & Amortization
-2m PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Depreciation & Amortization amounts to -2m PLN.

What is Medicofarma Biotech SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-95%

Over the last year, the Depreciation & Amortization growth was -14%. The average annual Depreciation & Amortization growth rates for Medicofarma Biotech SA have been -268% over the past three years , -95% over the past five years .

Back to Top